<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00153257</url>
  </required_header>
  <id_info>
    <org_study_id>P040306</org_study_id>
    <secondary_id>CRC04001</secondary_id>
    <nct_id>NCT00153257</nct_id>
  </id_info>
  <brief_title>Comparative Study of Mesh Versus No Mesh in Prolapse Surgery</brief_title>
  <official_title>Comparison of the Prosthesis Ugytex by the Trans-obturator Approach and Anterior Colporrhaphy for the Surgical Treatment of Anterior Vaginal Wall Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DRRC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis / aims of study A RCT has shown that results of prolapse repair via vaginal
      approach could be improved when a polypropylene mesh is used as tissue support (1). However,
      non protected heavy-weight meshes were associated with a high rate of local complications
      such as vaginal erosions and dyspareunia (2). The aim of this multicentre study is to
      evaluate anatomical and functional results of an innovative low-weight polypropylene mesh
      protected by an absorbable hydrophilic film in the prolapse repair by vaginal route, in
      comparison by the standard anterior colporrhaphy.

      Study design, materials and methods This study involves 15 centres in French Private or
      Public Hospital. Patients will be randomly allocated to be operated by a standard anterior
      colporrhaphy or by an anterior repair reinforced by a specially designed mesh: UgytexTM
      (Sofradim, France). Ugytex is a low-weight (38g/m²) and highly porous (average porosity: 89%,
      pores over 1.5mm) polypropylene monofilament mesh offering tissue ingrowth and connective
      differentiation for a stable and long-term support. The mesh is coated with a hydrophilic
      film composed of atelocollagen, polyethylene glycol and glycerol. The absorbable coating
      protects delicate pelvic viscera from the risk of acute inflammation during the healing's
      inflammatory peak. Prolapse severity will be evaluated using the POP-Q system. In order to
      evaluate the patient's quality of life, the validated PFDI and the PFIQ questionnaires will
      be used preoperatively and during follow-up (3), as well as a validated questionnaire on
      sexual problems. The difference on one-year cure rate should be 15% (80% for the anterior
      colporrhaphy and 95% for the mesh repair). Then the estimated number of patient is 97 in each
      arm.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of anatomical recurrences of anterior vaginal wall prolapse of stage 2 or more (POP-Q system)</measure>
    <time_frame>1 year</time_frame>
    <description>POP-Q score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative and postoperative morbidity</measure>
    <time_frame>3 years</time_frame>
    <description>Number of Major and minor complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functionnal results following intervention</measure>
    <time_frame>3 years</time_frame>
    <description>Symptoms and quality of life questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of local complications of prosthesis (vaginal erosion, prosthesis shrinkage)</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative sexuality</measure>
    <time_frame>3 years</time_frame>
    <description>PISQ score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">162</enrollment>
  <condition>Vaginal Prolapse</condition>
  <condition>Cystocele</condition>
  <arm_group>
    <arm_group_label>Ugytex</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Anterior repair reinforced by a specially designed mesh: UgytexTM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No device</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard anterior colporrhaphy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ugytex</intervention_name>
    <description>Anterior repair reinforced by a specially designed mesh: UgytexTM</description>
    <arm_group_label>Ugytex</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 60 years-old

          -  Anterior vaginal wall prolapse of stage 2 or more (POP-Q system)

          -  Symptomatic prolapse

          -  Informed consent signature obtained

        Exclusion Criteria:

          -  Patient not able to read French language

          -  Patient with a anterior prolapse of stage 1

          -  Urinary of vaginal infection

          -  Hepatopathy with ascitis

          -  Diabetes uncontrolled

          -  Treatment by corticosteroids

          -  Previous pelvic irradiation

          -  Intraoperative bladder injury
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé Fernandez, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpital Béclère, Clamart, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Carémeau</name>
      <address>
        <city>Nimes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystocele</mesh_term>
    <mesh_term>Uterine Prolapse</mesh_term>
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

